Medicine and Dentistry
Patient
100%
Lipid
54%
Therapeutic Procedure
51%
Cardiovascular Risk
50%
Cardiovascular Disease
36%
Risk Evaluation
25%
Diabetes
24%
Statin
23%
Human Immunodeficiency Virus
23%
Hyperlipidemia
22%
Marker
21%
Disease
20%
Hypertriglyceridemia
18%
Primary Prevention
16%
Apolipoprotein B100
15%
Refsum Disease
15%
Man
15%
Hypercholesterolemia
14%
Hypertension
14%
Ischemic Heart Disease
14%
Cardiovascular System
14%
Very Low Density Lipoprotein
12%
Drug Therapy
11%
Consensus
11%
Woman
11%
Blood Pressure
11%
Metabolic Syndrome
11%
Apoplexy
11%
Adult
11%
Atherosclerosis
11%
Diabetes Mellitus
11%
Cardiometabolic Risk
11%
Triacylglycerol
11%
Lifespan
9%
Lifestyle
9%
Screening
9%
Phytanic Acid
9%
Prevalence
9%
Gender
8%
Hypolipidemic Agent
8%
Monotherapy
8%
Highly Active Antiretroviral Therapy
8%
Low-Density Lipoprotein
7%
Aortic Stenosis
7%
Sodium
7%
Erectile Dysfunction
7%
Acute Kidney Injury
7%
Rhabdomyolysis
7%
Hormone Replacement Therapy
7%
Combined Hyperlipidemia
7%
Biochemistry, Genetics and Molecular Biology
Lipid
33%
Triglyceride
32%
Kinetics
23%
Metabolic Pathway
23%
Gene
18%
HDL-Cholesterol
18%
Hyperlipidemia
12%
Reduction (Chemistry)
11%
Blood Lipids
11%
Enzyme
10%
Alpha Oxidation
9%
Phylloquinone
7%
Gene Linkage
7%
Heparin
5%